INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM);UNIVERSITE PAUL SABATIER TOULOUSE III;CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE
发明人:
Vincent BLASCO-BAQUE,Lucile GARIDOU,Rémy BURCELIN
申请号：
US16061830
公开号：
US20180369353A1
申请日:
2016.12.15
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention concerns a composition comprising at least one prophylactically or therapeutically active agent selected from the group consisting of attenuated Porphyromonas gingivalis, inactivated Porphyromonas gingivalis, a subunit of Porphyromonas gingivalis, a recombinant or isolated immunogenic polypeptide or peptide from Porphyromonas gingivalis or a c DNA from Porphyromonas gingivalis, for use as a vaccine for preventing or treating periodontitis, diabetes, obesity and/or complications thereof in a subject. The present invention also concerns an isolated antibody having specificity for Porphyromonas gingivalis for use for preventing or treating periodontitis, diabetes, obesity and/or complications thereof in a subject.
